(Finance) – The COVID-19 pandemic has highlighted the need for Europe to be better prepared for future health emergencies. The EU4Health program reflects this need well: protecting citizens from cross-border health threats is among its funding priorities. on behalf ofHealth Emergency Preparedness and Response Authority (HERA), theEuropean Executive Agency for Health and Digital (HaDEA) signed a contract Square with four contractors setting up the FAB network of the EU for sufficient and agile production capacities for different types of vaccines (mRNA-based vectors, protein-based). These capabilities will be kept operational and can be activated quickly, ensuring a total of 325 million doses per year in the event of a public health emergency.
The EU FAB network includes manufacturers Of vaccines in the EU (Belgium, Ireland, Netherlands, Spain). The network’s actions will bridge the gap between manufacturing and scaling up vaccine production, while ensuring industry’s capacity to produce life-saving medicines.
EU FABs will reserve production capacity for the EU to produce vaccines in case of public health emergencies, covering production capacities for vaccines based on mRNA, carriers And protein.